193 related articles for article (PubMed ID: 387136)
1. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
Aquinas M
Bull Int Union Tuberc; 1978 Dec; 53(4):253. PubMed ID: 387136
[No Abstract] [Full Text] [Related]
2. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council].
Chaulet P
Bull Int Union Tuberc; 1985; 60(1-2):31-3. PubMed ID: 4074970
[No Abstract] [Full Text] [Related]
4. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
Pretet S; Grosset J; Perdrizet S
Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140
[No Abstract] [Full Text] [Related]
5. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis treatment: dangerous regimens?
Rieder HL; Arnadottir T; Trébucq A; Enarson DA
Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
[No Abstract] [Full Text] [Related]
7. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.
Am Rev Respir Dis; 1987 Dec; 136(6):1339-42. PubMed ID: 2891333
[TBL] [Abstract][Full Text] [Related]
8. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
9. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
10. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
[TBL] [Abstract][Full Text] [Related]
11. [Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].
Bouslama A; Hedhiri H; Marzouki M; Jerray M; Djenayah F
Bull Int Union Tuberc; 1985; 60(1-2):29-30. PubMed ID: 4074969
[No Abstract] [Full Text] [Related]
12. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
Utkin VV
Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901
[No Abstract] [Full Text] [Related]
13. Short-course drug therapy for tuberculosis.
Stratton MA; Reed MT
Clin Pharm; 1986 Dec; 5(12):977-87. PubMed ID: 3542345
[TBL] [Abstract][Full Text] [Related]
14. [Short-course chemotherapy of tuberculosis with pyrazinamide].
Asai S; Futsuki Y; Tomari S; Araki J
Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
[TBL] [Abstract][Full Text] [Related]
15. Short-course (6-month) treatment of pulmonary tuberculosis (Second East African/British Medical Research Council Study).
Jindani A
Bull Int Union Tuberc; 1976; 51(1):53-6. PubMed ID: 71178
[No Abstract] [Full Text] [Related]
16. A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association.
Am Rev Respir Dis; 1982 Sep; 126(3):460-2. PubMed ID: 6751175
[TBL] [Abstract][Full Text] [Related]
17. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
Trébucq A; Rieder HL
Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
[No Abstract] [Full Text] [Related]
18. [New and future drugs in pulmonary tuberculosis].
Grosset JH; Truffot-Pernot C; Lecoeur H
Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565
[No Abstract] [Full Text] [Related]
19. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
Pilipchuk NS
Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
[No Abstract] [Full Text] [Related]
20. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]